CoChat
Sign Up
Cited by 40

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Modelling the intervention effect of opioid agonist treatment on multiple mortality outcomes in people who inject drugs: a three-setting analysis

Stone, Jack, Degenhardt, Louisa, Grebely, Jason, Larney, Sarah, Altice, Frederick L, Smyrnov, Pavlo, Rahimi-Movaghar, Afarin, Alavi, Maryam, Young, April M, Havens, Jennifer R, Miller, William C, Hickman, Matthew, Vickerman, Peter·2021·The Lancet Psychiatry
DOI 10.1016/s2215-0366(20)30538-1PMC PMC8255389
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s2215-0366(20)30538-1

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 26

  1. Degenhardt, 2012, Extent of illicit drug use and dependence, and their contribution to the global burden of disease, Lancet, 379, 55, 10.1016/S0140-6736(11)61138-0 · DOI
  2. Degenhardt, 2017, Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review, Lancet Glob Health, 5, e1192, 10.1016/S2214-109X(17)30375-3 · DOI
  3. Stone, 2018, Incarceration history and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis, Lancet Infect Dis, 18, 1397, 10.1016/S1473-3099(18)30469-9 · DOI
  4. Merrall, 2010, Meta-analysis of drug-related deaths soon after release from prison, Addiction, 105, 1545, 10.1111/j.1360-0443.2010.02990.x · DOI
  5. Degenhardt, 2019, Global patterns of opioid use and dependence: harms to populations, interventions, and future action, Lancet, 394, 1560, 10.1016/S0140-6736(19)32229-9 · DOI
  6. MacArthur, 2012, Opiate substitution treatment and HIV transmission in people who inject drugs: systematic review and meta-analysis, BMJ, 345, 10.1136/bmj.e5945 · DOI · Paper page
  7. Platt, 2017, Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs, Cochrane Database Syst Rev, 9
  8. Larney, 2014, Opioid substitution therapy as a strategy to reduce deaths in prison: retrospective cohort study, BMJ Open, 4, 10.1136/bmjopen-2013-004666 · DOI
  9. Low, 2016, Impact of opioid substitution therapy on antiretroviral therapy outcomes: a systematic review and meta-analysis, Clin Infect Dis, 63, 1094, 10.1093/cid/ciw416 · DOI
  10. Degenhardt, 2009, Mortality among clients of a state-wide opioid pharmacotherapy program over 20 years: risk factors and lives saved, Drug Alcohol Depend, 105, 9, 10.1016/j.drugalcdep.2009.05.021 · DOI
  11. Larney, 2012, Effect of prison-based opioid substitution treatment and post-release retention in treatment on risk of re-incarceration, Addiction, 107, 372, 10.1111/j.1360-0443.2011.03618.x · DOI
  12. Larney, 2017, Global, regional, and country-level coverage of interventions to prevent and manage HIV and hepatitis C among people who inject drugs: a systematic review, Lancet Glob Health, 5, e1208, 10.1016/S2214-109X(17)30373-X · DOI
  13. Xia, 2015, Factors affecting repeated cessations of injecting drug use and relapses during the entire injecting career among the Edinburgh Addiction Cohort, Drug Alcohol Depend, 151, 76, 10.1016/j.drugalcdep.2015.03.005 · DOI
  14. Kimber, 2010, Survival and cessation in injecting drug users: prospective observational study of outcomes and effect of opiate substitution treatment, BMJ, 341, 10.1136/bmj.c3172 · DOI
  15. Young, 2012, Transition from first illicit drug use to first injection drug use among rural Appalachian drug users: a cross-sectional comparison and retrospective survival analysis, Addiction, 107, 587, 10.1111/j.1360-0443.2011.03635.x · DOI
  16. Stone, 2020, Modeling the role of incarceration in HCV transmission and prevention amongst people who inject drugs in rural Kentucky, Int J Drug Policy
  17. Fraser, 2019, Scaling up hepatitis C prevention and treatment interventions for achieving elimination in the United States: a rural and urban comparison, Am J Epidemiol, 188, 1539, 10.1093/aje/kwz097 · DOI
  18. Zelenev, 2019, Estimating HIV and HCV prevalence among people who inject drugs in 5 Ukrainian cities using stratification-based respondent driven and random sampling, Int J Drug Policy, 67, 91, 10.1016/j.drugpo.2018.09.010 · DOI
  19. Miller, 2018, A scalable, integrated intervention to engage people who inject drugs in HIV care and medication-assisted treatment (HPTN 074): a randomised, controlled phase 3 feasibility and efficacy study, Lancet, 392, 747, 10.1016/S0140-6736(18)31487-9 · DOI
  20. Rahimi-Movahgar, 2011, Compulsory methadone maintenance treatment of severe cases of drug addiction in a residential setting in Tehran, Iran: outcome evaluation in two and six-month follow-up, Payesh Health Monitor, 10, 505
  21. Jafari, 2010, A follow-up study of drug users in Southern Iran, Addict Res Theory, 18, 59, 10.3109/16066350902825930 · DOI
  22. Hickman, 2018, The impact of buprenorphine and methadone on mortality: a primary care cohort study in the United Kingdom, Addiction, 113, 1461, 10.1111/add.14188 · DOI
  23. Cepeda, 2018, Potential impact of implementing and scaling up harm reduction and antiretroviral therapy on HIV prevalence and mortality and overdose deaths among people who inject drugs in two Russian cities: a modelling study, Lancet HIV, 5, e578, 10.1016/S2352-3018(18)30168-1 · DOI
  24. Mukandavire, 2017, Impact of opioid substitution therapy on the HIV prevention benefit of antiretroviral therapy for people who inject drugs, AIDS, 31, 1181, 10.1097/QAD.0000000000001458 · DOI
  25. Alistar, 2011, Effectiveness and cost effectiveness of expanding harm reduction and antiretroviral therapy in a mixed HIV epidemic: a modeling analysis for Ukraine, PLoS Med, 8, 10.1371/journal.pmed.1000423 · DOI
  26. Altice, 2016, The perfect storm: incarceration and the high-risk environment perpetuating transmission of HIV, hepatitis C virus, and tuberculosis in Eastern Europe and Central Asia, Lancet, 388, 1228, 10.1016/S0140-6736(16)30856-X · DOI

Cited by

Sorted by citations

See all 40

Metadata

Authors
Stone, J., Degenhardt, L., Grebely, J., Larney, S., Altice, F. L., Smyrnov, P., Rahimi-Movaghar, A., Alavi, M., Young, A. M., Havens, J. R., Miller, W. C., Hickman, M., & Vickerman, P.
Venue
The Lancet Psychiatry
Publisher
Elsevier BV
Published
2021-04
Volume
8
Issue
4
Pages
301-309
ISSN
2215-0366
DOI
10.1016/s2215-0366(20)30538-1
PMC
PMC8255389
Cited by
40
References
1
Language
en
Licence
Funders
  • National Institute for Health Research
  • National Institute on Drug Abuse

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Modelling the intervention effect of opioid agonist treatment on multiple mortality outcomes in people who inject drugs: a three-setting analysis. https://app.cochat.ai/papers/10.1016/s2215-0366(20)30538-1
The paper
Stone, J., Degenhardt, L., Grebely, J., Larney, S., Altice, F. L., Smyrnov, P., Rahimi-Movaghar, A., Alavi, M., Young, A. M., Havens, J. R., Miller, W. C., Hickman, M., & Vickerman, P. (2021). Modelling the intervention effect of opioid agonist treatment on multiple mortality outcomes in people who inject drugs: a three-setting analysis. The Lancet Psychiatry. https://doi.org/10.1016/s2215-0366(20)30538-1